Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (5) Cakmak-Görür, Nese Dr. (1) Daniel, Peter Prof. Dr. (2) Dhamodaran, Arunraj (1) Gerhardt, Holger Prof. Dr. (1) Hübner, Norbert Prof. Dr. (1) Kammertöns, Thomas Dr. (8) Keller, Ulrich Dr. med. (1) Kopp, Joachim Dr. (2) Kunz, Severine Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (5) Lorenz, Felix Dr. (1) Marko, Lajos Dr. (1) Mertins, Philipp Dr. (2) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (4) Poncette, Lucia (3) Popp, Oliver Dr. (2) Rahn, Hans-Peter Dr. (1) Rhein, Simone Dr. (2) Rosenberger, Leonie Milena (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (5) Willimsky, Gerald Dr. (6) (-) Blankenstein, Thomas Prof. Dr. (26) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) (-) 2011 (5) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) (-) 2017 (6) 2018 (4) (-) 2019 (6) 2021 (4) (-) 2022 (6) 2023 (4) 2024 (2) Bioinformatics and Omics Data Science (1) Biology of Malignant Lymphomas (23) Cancer Genetics and Cellular Stress Responses (2) Flow Cytometry (1) Genetics and Genomics of Cardiovascular Diseases (2) Immune Dysregulations in Oncology (1) Integrative Vascular Biology (1) Mechanism-based Cancer Therapies (3) (-) Molecular Immunology and Gene Therapy (26) Proteome Dynamics (1) Proteomics (2) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (1) Translational Bioinformatics (5) 26 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Molecular Immunology and Gene Therapy20112015201720192022 Sort: Result score Newest to oldest Oldest to newest October 27, 2022 / J Immunother Cancer H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky February 01, 2022 / Curr Opin Immunol The role of CD4 T cells in rejection of solid tumors L. Poncette J. Bluhm T. Blankenstein August 01, 2022 / Cytotherapy Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy M.F. Lammoglia Cobo C. Welters L. Rosenberger M. Leisegang K. Dietze C. Pircher L. Penter R. Gary L. Bullinger A. Takvorian A. Moosmann K. Dornmair T. Blankenstein T. Kammertöns A. Gerbitz L. Hansmann April 06, 2022 / Cancers Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires C. Grunert G. Willimsky C.A. Peuker S. Rhein L. Hansmann T. Blankenstein E. Blanc D. Beule U. Keller A. Pezzutto A. Busse June 08, 2022 / Sci Adv IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis L. Garnier R. Pick J. Montorfani M. Sun D. Brighouse N. Liaudet T. Kammertoens T. Blankenstein N. Page J. Bernier-Latamani N.L. Tran T.V. Petrova D. Merkler C. Scheiermann S. Hugues March 24, 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann November 01, 2022 / Cancer Immunol Res Immune phenotypes and target antigens of clonally expanded bone marrow T cells in treatment-naïve multiple myeloma C. Welters M.F. Lammoglia Cobo C.A. Stein M.T. Hsu A. Ben Hamza L. Penter X. Chen C. Buccitelli O. Popp P. Mertins K. Dietze L. Bullinger A. Moosmann E. Blanc D. Beule A. Gerbitz J. Strobel H. Hackstein H.P. Rahn K. Dornmair T. Blankenstein L. Hansmann July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein November 01, 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
October 27, 2022 / J Immunother Cancer H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky
February 01, 2022 / Curr Opin Immunol The role of CD4 T cells in rejection of solid tumors L. Poncette J. Bluhm T. Blankenstein
August 01, 2022 / Cytotherapy Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy M.F. Lammoglia Cobo C. Welters L. Rosenberger M. Leisegang K. Dietze C. Pircher L. Penter R. Gary L. Bullinger A. Takvorian A. Moosmann K. Dornmair T. Blankenstein T. Kammertöns A. Gerbitz L. Hansmann
April 06, 2022 / Cancers Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires C. Grunert G. Willimsky C.A. Peuker S. Rhein L. Hansmann T. Blankenstein E. Blanc D. Beule U. Keller A. Pezzutto A. Busse
June 08, 2022 / Sci Adv IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis L. Garnier R. Pick J. Montorfani M. Sun D. Brighouse N. Liaudet T. Kammertoens T. Blankenstein N. Page J. Bernier-Latamani N.L. Tran T.V. Petrova D. Merkler C. Scheiermann S. Hugues
March 24, 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann
November 01, 2022 / Cancer Immunol Res Immune phenotypes and target antigens of clonally expanded bone marrow T cells in treatment-naïve multiple myeloma C. Welters M.F. Lammoglia Cobo C.A. Stein M.T. Hsu A. Ben Hamza L. Penter X. Chen C. Buccitelli O. Popp P. Mertins K. Dietze L. Bullinger A. Moosmann E. Blanc D. Beule A. Gerbitz J. Strobel H. Hackstein H.P. Rahn K. Dornmair T. Blankenstein L. Hansmann
July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
November 01, 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein
January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens